Eli Lilly and Company (LLY) – Investment Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Eli Lilly and Company (NYSE: LLY) in the last few weeks: 11/4/2024 – Eli Lilly and Company was upgraded by analysts at Redburn Atlantic to a “hold” rating. 11/4/2024 – Eli Lilly and Company had its price target lowered by analysts at Deutsche […]
More Stories
American Healthcare REIT (NYSE:AHR) Releases Quarterly Earnings Results, Misses Estimates By $0.35 EPS
American Healthcare REIT (NYSE:AHR – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.03) earnings...
Lifeworks Advisors LLC Cuts Stake in Texas Instruments Incorporated (NASDAQ:TXN)
Lifeworks Advisors LLC reduced its stake in shares of Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 5.7% during the...
MeadowBrook Investment Advisors LLC Reduces Position in Stryker Co. (NYSE:SYK)
MeadowBrook Investment Advisors LLC trimmed its holdings in Stryker Co. (NYSE:SYK – Free Report) by 4.5% during the third quarter,...
scPharmaceuticals (NASDAQ:SCPH) Earns “Buy” Rating from HC Wainwright
scPharmaceuticals (NASDAQ:SCPH – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in...
BWS Financial Reaffirms Buy Rating for Net Lease Office Properties (NYSE:NLOP)
Net Lease Office Properties (NYSE:NLOP – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at BWS Financial...
Short Interest in Cochlear Limited (OTCMKTS:CHEOY) Decreases By 91.0%
Cochlear Limited (OTCMKTS:CHEOY – Get Free Report) was the target of a large drop in short interest in the month...